deaths (OS)

Extensive stage SCLC (Es-SCLC) - 1st Line (L1) Extensive stage SCLC (Es-SCLC) Extensive stage SCLC (Es-SCLC) - 1st Line (L1)

versus placebo plus SoC
atezolizumab plus SoC vs. placebo plus SoC 1 -1460 [-2409; -510] /10000
104/201 vs. 134/202